Document ID: chunk:federal_register_of_legislation:F2024L01730:schedule:1:p19
Version: federal_register_of_legislation:F2024L01730
Segment Type: schedule
Provision Reference: sch 1 (pt 19/30)
Character Range: 53840–56758

Capsule 12.5 mg  Oral  Sunitinib MSN  LR  MP  C4862                    28  2     28
Sunitinib  Capsule 12.5 mg  Oral  Sunitinib MSN  LR  MP  C11875                   28  3     28
Sunitinib  Capsule 12.5 mg  Oral  Sunitinib MSN  LR  MP  C7471                    28  5     28

[119] Schedule 1, Part 1, entries for Sunitinib in the form Capsule 25 mg
omit:
Sunitinib  Capsule 25 mg  Oral  Sunitinib MSN  LR  MP  C11878 C13152 C13153     28  1     28
Sunitinib  Capsule 25 mg  Oral  Sunitinib MSN  LR  MP  C4862                    28  2     28
Sunitinib  Capsule 25 mg  Oral  Sunitinib MSN  LR  MP  C11875                   28  3     28
Sunitinib  Capsule 25 mg  Oral  Sunitinib MSN  LR  MP  C7471                    28  5     28

[120] Schedule 1, Part 1, entries for Sunitinib in the form Capsule 37.5 mg
omit:
Sunitinib  Capsule 37.5 mg  Oral  Sunitinib MSN  LR  MP  C11878 C13152 C13153     28  1     28
Sunitinib  Capsule 37.5 mg  Oral  Sunitinib MSN  LR  MP  C4862                    28  2     28
Sunitinib  Capsule 37.5 mg  Oral  Sunitinib MSN  LR  MP  C11875                   28  3     28
Sunitinib  Capsule 37.5 mg  Oral  Sunitinib MSN  LR  MP  C7471                    28  5     28

[121] Schedule 1, Part 1, entries for Sunitinib in the form Capsule 50 mg
omit:
Sunitinib  Capsule 50 mg  Oral  Sunitinib MSN  LR  MP  C11878 C13152 C13153     28  1     28
Sunitinib  Capsule 50 mg  Oral  Sunitinib MSN  LR  MP  C4862                    28  2     28
Sunitinib  Capsule 50 mg  Oral  Sunitinib MSN  LR  MP  C11875                   28  3     28
Sunitinib  Capsule 50 mg  Oral  Sunitinib MSN  LR  MP  C7471                    28  5     28

[122] Schedule 1, Part 1, after entry for Tafamidis
insert:
Talazoparib  Capsule 100 micrograms (as tosilate)  Oral  Talzenna  PF  MP  C16224     30  5     30
Talazoparib  Capsule 250 micrograms (as tosilate)  Oral  Talzenna  PF  MP  C16224     30  5     30
Talazoparib  Capsule 350 micrograms (as tosilate)  Oral  Talzenna  PF  MP  C16224     30  5     30
Talazoparib  Capsule 500 micrograms (as tosilate)  Oral  Talzenna  PF  MP  C16224     30  5     30

[123] Schedule 1, Part 1, entries for Telmisartan in the form Tablet 80 mg
omit:
Telmisartan  Tablet 80 mg  Oral  NOUMED TELMISARTAN  VO  MP NP             28  5     28
Telmisartan  Tablet 80 mg  Oral  NOUMED TELMISARTAN  VO  MP NP     P14238  56  5     28

[124] Schedule 1, Part 1, entry for Tofacitinib in the form Oral solution 1 mg per mL, 240 mL [Maximum Quantity: 1; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14647
(b) omit from the column headed "Purposes": P14647
[125] Schedule 1, Part 1, entry for Tofacitinib in the form Tablet 5 mg [Maximum Quantity: 56; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14647
(b) omit from the column headed "Purposes": P14647
[126] Schedule 1, Part 1, entry for Ustekinumab in the form Injection 90 mg in 1 mL single